---
title: "Dr. Pedro Martinez-Clark, MD, FACC — Founder & Lead Investigator | Amavita Research"
url: https://md.amavitaresearch.com/team/pedro-martinez-clark
canonical: https://www.amavitaresearch.com/team/pedro-martinez-clark
schema_type: ProfilePage
last_updated: 2026-05-13
---

# Dr. Pedro Martinez-Clark, MD, FACC

**Founder and Lead Investigator at Amavita Research. Founder of amavita Heart and Vascular Health® (the cardiology practice).**

Harvard-trained interventional cardiologist with 15+ years of practice and 25+ completed clinical research trials. Currently Principal Investigator on the GREAT trial — a Phase 3 study of the Golazo® below-the-knee peripheral atherectomy device (Avantec/CSI). Worldwide Principal Investigator on the Percutaneous Mitral Valve Annuloplasty trial. Contributed to the development of the Trans-Caval TAVR approach. 2023 Apogee Award for Excellence in Healthcare.

## Specialties

- Interventional cardiology and cath lab
- Coronary revascularization
- Heart valve repair and replacement (Trans-Caval TAVR)
- Peripheral artery disease and below-the-knee atherectomy
- Venous ablation

## Current active trial as PI

- **GREAT (Golazo® peripheral atherectomy)** — Avantec/CSI, Phase 3 PAD. https://www.amavitaresearch.com/trials/golazo-great

## Marquee historical trials

- Percutaneous Mitral Valve Annuloplasty (Worldwide PI)
- Trans-Caval TAVR (development contributor)
- CYCLE (heart failure)
- CHAMP-HF Registry
- Pathfinder I (AURYON)
- SPARE-MR

## Affiliations

- Founder and Lead Investigator, Amavita Research
- Founder, amavita Heart and Vascular Health® (cardiology practice — parent of the research arm): https://amavita.health
- Co-founder, Advanced Cardiovascular of Miami (ambulatory surgical center): https://www.advancedcvmiami.com

## Identifiers

- Wikidata: https://www.wikidata.org/wiki/Q139556853